AbbVie lifts annual profit forecast on strong demand for newer immunology drugs
Yahoo Financearrow_outwardAbbVie Stock Rises On Earnings Beat, Guidance Hike
Barron'sarrow_outwardIs ABBV Stock (ABBV) a Buy Ahead of Q2 Earnings?
TipRanksarrow_outwardAbbVie stock gains as company posts Q2 beat (ABBV:NYSE) - Seeking Alpha
Seeking Alphaarrow_outwardAbbVie’s (NYSE:ABBV) Q2: Beats On Revenue - TradingView
TradingViewarrow_outwardAbbVie Reports Second-Quarter 2025 Financial Results - PR Newswire
PR Newswirearrow_outwardWhat catalysts could drive ABBV stock higher in 2025 - Market Forecast Entry Points For Smart Trading - jammulinksnews.com
Jammulinksnews.comarrow_outwardHow Interest Rate Changes Impact ABBV Stock Performance - ROI Driven Equity Selection With Safety Emphasized - metal.it
Metal.itarrow_outwardSell AbbVie Stock Ahead of Its Upcoming Earnings? - Forbes
Forbesarrow_outwardAbbVie (ABBV) Reports Q2: Everything You Need To Know Ahead Of Earnings - FinancialContent
FinancialContentarrow_outwardAbbVie (ABBV) Files sNDA For Oral VENCLEXTA Combo Regimen In CLL Treatment - simplywall.st
Simplywall.starrow_outwardPre-Q2 Earnings: Is AbbVie Stock a Portfolio Must-Have? - Zacks Investment Research
Zacks Investment Researcharrow_outwardAbbVie Inc. (ABBV) Stock Analysis: Evaluating a 9.92% Potential Upside with Strong Buy Consensus - DirectorsTalk Interviews
DirectorsTalk Interviewsarrow_outwardWhy AbbVie (ABBV) Is a High-Conviction Buy Despite Mixed Analyst Sentiment - AInvest
AInvestarrow_outwardAbbVie (ABBV) Positioned for Growth With Strong Skyrizi, Rinvoq Sales, Says JPMorgan - Insider Monkey
Insider Monkeyarrow_outwardThe Smartest Dividend Stocks to Buy With $350 Right Now - The Globe and Mail
The Globe and Mailarrow_outwardABBV Stock Analysis and Forecast - Free Trend-Following Techniques - Autocar Professional
Autocar Professionalarrow_outwardAbbVie Stock (ABBV) Opinions on Recent Price Surge and Sales Growth - Quiver Quantitative
Quiver Quantitativearrow_outwardHere's What To Expect From AbbVie's Next Earnings Report - Barchart.com
Barchart.comarrow_outward2 Dividend Stocks to Buy for Decades of Passive Income - The Motley Fool
The Motley Foolarrow_outwardHow AbbVie is Engineering Its Next Growth Phase - Trefis
Trefisarrow_outward$ABBV stock is up 2% today. Here's what we see in our data. - Nasdaq
Nasdaqarrow_outwardIs AbbVie the Best Dividend Stock in Big Pharma Today? - MSN
MSNarrow_outwardAbbVie declares quarterly dividend of $1.64 per share - Investing.com
Investing.comarrow_outwardS&P 500 Gains and Losses Today: AbbVie Stock Advances After Beat-and-Raise Earnings Report - Investopedia
Investopediaarrow_outwardAbbVie Hikes Its Outlook On The Back Of Two Powerhouse Drugs - Investor's Business Daily
Investor's Business Dailyarrow_outward
Abbv Stock close
- 2025-07-31 20:30 event
- 26 sourceslanguage
- 200+ ads_click
- 22 hours ago schedule